Literature DB >> 12358224

Ocular manifestations of autoimmune disease.

Sayjal J Patel1, Diane C Lundy.   

Abstract

Rheumatoid arthritis, juvenile rheumatoid arthritis, Sjögren's syndrome, the seronegative spondyloarthropathies, systemic lupus erythematosus, multiple sclerosis, giant cell arteritis, and Graves' disease are autoimmune disorders commonly encountered by family physicians. These autoimmune disorders can have devastating systemic and ocular effects. Ocular symptoms may include dry or red eyes, foreign-body sensation, pruritus, photophobia, pain, visual changes, and even complete loss of vision. Because a number of these diseases may initially present with ocular symptoms, physicians should maintain a high index of suspicion to make a timely diagnosis. A thorough ophthalmic examination, including visual acuity, pupillary reaction, ocular motility, confrontation field testing, external inspection, and direct ophthalmoscopy with fluorescein staining, should be completed. In the patient with the complaint of a "dry eye" or a "red eye," simple tools such as the Schirmer's test or the blanching effect of phenylephrine can be useful in diagnosis. In general, managing the systemic effects with nonsteroidal anti-inflammatory drugs, corticosteroids, and immunosuppressive agents controls the ocular symptoms. When visual function is threatened, surgical therapy may be necessary. Early and accurate diagnosis with prompt treatment or referral to an ophthalmologist may prevent systemic and ocular disabilities.

Entities:  

Mesh:

Year:  2002        PMID: 12358224

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  28 in total

1.  The treatment of dry eyes.

Authors:  J P Whitcher
Journal:  Br J Ophthalmol       Date:  2004-05       Impact factor: 4.638

2.  Role of epithelial-mesenchymal transition in repair of the lacrimal gland after experimentally induced injury.

Authors:  Samantha You; Orna Avidan; Ayesha Tariq; Ivy Ahluwalia; Paul C Stark; Claire L Kublin; Driss Zoukhri
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-17       Impact factor: 4.799

Review 3.  Mechanisms involved in injury and repair of the murine lacrimal gland: role of programmed cell death and mesenchymal stem cells.

Authors:  Driss Zoukhri
Journal:  Ocul Surf       Date:  2010-04       Impact factor: 5.033

Review 4.  Understanding the role of aldose reductase in ocular inflammation.

Authors:  U C S Yadav; S K Srivastava; K V Ramana
Journal:  Curr Mol Med       Date:  2010-08       Impact factor: 2.222

Review 5.  Effect of inflammation on lacrimal gland function.

Authors:  Driss Zoukhri
Journal:  Exp Eye Res       Date:  2005-11-23       Impact factor: 3.467

6.  Biomechanical evaluation of cornea in patients with ankylosing spondylitis.

Authors:  Mehtap Caglayan; Ozge Sarac; Pinar Kosekahya; Sukran Erten; Berna Ayan; Nurullah Cagil
Journal:  Int Ophthalmol       Date:  2016-10-05       Impact factor: 2.031

7.  TH17 cells mediate inflammation in a novel model of spontaneous experimental autoimmune lacrimal keratoconjunctivitis with neural damage.

Authors:  Kyoung Yul Seo; Kazuya Kitamura; Soo Jung Han; Brian Kelsall
Journal:  J Allergy Clin Immunol       Date:  2017-09-27       Impact factor: 10.793

Review 8.  The retina as a window to the brain-from eye research to CNS disorders.

Authors:  Anat London; Inbal Benhar; Michal Schwartz
Journal:  Nat Rev Neurol       Date:  2012-11-20       Impact factor: 42.937

9.  Ocular Inflammation in the Setting of Concomitant Systemic Autoimmune Conditions in an Older Male Population.

Authors:  Alexandra E Levitt; Katherine T McManus; Allison L McClellan; Janet L Davis; Raquel Goldhardt; Anat Galor
Journal:  Cornea       Date:  2015-07       Impact factor: 2.651

Review 10.  Autologous serum eye drops for dry eye.

Authors:  Qing Pan; Adla Angelina; Andrea Zambrano; Michael Marrone; Walter J Stark; Thomas Heflin; Li Tang; Esen K Akpek
Journal:  Cochrane Database Syst Rev       Date:  2013-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.